CNBG’s Sinopharm vaccine has been approved for emergency use by the World Health Organisation (WHO).
The organisation recommended the inactivated vaccine be administered after assessing the quality, safety and efficacy of the shot.
The listing represents an important endorsement of the vaccine, which has yet to release data from late stage trials in a medical journal.
“This afternoon, WHO gave emergency use listing to Sinopharm Beijing’s Covid-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality,” the UN health agency’s director-general Tedros Adhanom Ghebreyesus told a news conference.
World Health Organisation Director General